EAST BRUNSWICK, N.J., June 5, 2009 (GLOBE NEWSWIRE) -- Savient Pharmaceuticals, Inc. (Nasdaq:SVNT) today announced that Ginger D. Constantine, M.D. has been elected to the Company’s Board of Directors. Dr. Constantine currently serves as Vice President of Women’s Health & Bone Repair Medical Research at Wyeth Research, a division of Wyeth Pharmaceuticals. Since 1992, Dr. Constantine has held various management positions of increasing responsibility in the therapeutic areas of rheumatology, metabolism and bone repair within the Wyeth Pharmaceuticals and Wyeth Research organizations. Prior to joining Wyeth, Dr. Constantine was a practicing physician specializing in Rheumatology and Internal Medicine and has authored a number of articles, abstracts as well as presentations, in the area of rheumatology and arthritis for peer reviewed publications and meetings.
